Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Hot-press cushion material and manufacturing method of the same
Treatment of cancer using the sodium salt of a benzoic acid derivative
Image forming apparatus to automatically select a communication condition
Method and apparatus for token-based context caching
Method and system for billing based on color component histograms
Modular connector for touch sensitive device
Image reconstruction iterative method
  Randomly Featured Patents
Bellows for articulated vehicles
Separable slide fastener
Apparatus and method of reassembling ethernet data
Color powder for coating
Circuit for generation of logic variables, using multiplexes and inverters
Electrostatic precipitator construction having ladder bar spacers
Method of securing a battery terminal to an external wall
Lens used for light-emitting diode
Cylindrical lithium ion secondary battery
Positioning apparatus